The city has won the 59th Congress of the International Society of Paediatric Oncology (SIOP) 2027 and the 39th World Congress of Audiology (WCA) for 2030.
The childhood cancer conference is expected to draw 2,200 delegates and have a direct spending impact of $7.7 million.
And in 2030, the global audiology meeting is anticipated to attract around 1,000 delegates and a spend of $5.9 million.
Sydney is a leader in the treatment of childhood cancers, through initiatives like the ZERO Childhood Cancer Program, described as the most comprehensive offering of its kind globally, offering personalised treatment recommendations to children based on in-depth analysis of them and their cancer.
“Collaboration is key to improving outcomes for children’s cancer and has been the bedrock of advancing the field for decades,” said Dr Richard Mitchell, director of the Kids Cancer Centre and the leader of the bid for the paediatric oncology meeting.
“Hosting the annual World Congress in Sydney will allow us to build new collaborations with the international community, leading to more therapies and better outcomes for Australian children with cancer.
“It will also allow us to showcase Australia’s amazing research and cutting-edge clinical care, and an opportunity to share our knowledge and skills with the international community.”
The conference received support from Australia’s subvention fund managed by Tourism Australia, the Business Events Bid Fund.
The president of local association, Audiology Australia, Dr Barbra Timmer was equally delighted with the international audiology meeting win.
“The International Society of Audiology’s decision to award Sydney 2030 opens up the world stage to our region to deliver a world-class scientific program that showcases our research, innovation and clinical leadership while driving connection across the world to benefit global hearing health,” she said.
BESydney’s CEO, Lyn Lewis-Smith, called the two wins “powerful vehicles for change that impact the lives of many globally”.
